Safety, tolerability, and efficacy of orally administered cannabinoids in MS. Killestein J, Hoogervorst ELJ, Reif M, Kalkers NF, Van Loenen AC, Staats PGM, Gorter RW, Uitdehaag BMJ, Polman CH Neurology. 2002 May 14; 58(9):1404-7. PMID: 12011290. Abstract CommentRecommendBookmarkWatch